| Name: | 4-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid |
| CAS Number: | 1510-21-0 |  3D/inchi
|
| ECHA EINECS - REACH Pre-Reg: | 216-148-6 |
| FDA UNII: | T3J4KS4201 |
| Nikkaji Web: | J206.716A |
| MDL: | MFCD00037705 |
| XlogP3-AA: | 8.50 (est) |
| Molecular Weight: | 486.73630000 |
| Formula: | C31 H50 O4 |
| NMR Predictor: | Predict (works with chrome, Edge or firefox) |
Category:emollients, skin conditioning
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00
|
| Food Chemicals Codex Listed: | No |
| Boiling Point: | 585.97 °C. @ 760.00 mm Hg (est)
|
| Flash Point: | 355.00 °F. TCC ( 179.60 °C. ) (est)
|
| logP (o/w): | 10.708 (est) |
| Soluble in: |
| | water, 1.702e-005 mg/L @ 25 °C (est) |
Organoleptic Properties:
| Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | | emollients, skin conditioning |
| Recommendation for cholesteryl succinate usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for cholesteryl succinate flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
| EPI System: View |
| AIDS Citations:Search |
| Cancer Citations:Search |
| Toxicology Citations:Search |
| EPA ACToR:Toxicology Data |
| EPA Substance Registry Services (SRS):Registry |
| Laboratory Chemical Safety Summary :65082 |
| National Institute of Allergy and Infectious Diseases:Data |
| WGK Germany:3 |
| 4-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid |
| Chemidplus:0001510210 |
References:
| | 4-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 65082 |
| Pubchem (sid): | 135022041 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | butanedioic acid, mono[(3b)-cholest-5-en-3-yl] ester | | 4-[(3b)- | cholest-5-en-3-yloxy]-4-oxobutanoic acid | | | cholest-5-en-3beta-yl hydrogen succinate | | | cholesterol hydrogen succinate | | | cholesteryl hemisuccinate | | | cholesteryl hydrogen succinate | | | cholesterylhemisuccinate | | 4-[[(3S,8S,9S,10R,13R,14S,17R)-10,13- | dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid | | 3b- | hydroxy-5-cholestene3-hemisuccinate |
Articles:
|
